Search

Search Results

• Favipiravir for the treatment of COVID-19 pneumonia: Can we predict the response to treatment?

  Abdullah Sayiner, Huseyin Aytac Erdem, Pervin Korkmaz Ekren, Sezai Tasbakan, Ozen K Basoglu, Meltem Isikgoz Tasbakan, Tansu Yamazhan, Deniz Gokengin, Mustafa Hikmet Ozhan

  422-426

  2022-03-31

• The safety and adverse event profile of favipiravir in the treatment of COVID-19 patients, Turkey

  Elif Tukenmez Tigen, Buket Erturk Sengel, Beste Ozben, Hande Perk Gurun, Baran Balcan, Beliz Bilgili, Fethi Gul, Zekaver Odabasi, Volkan Korten

  1549-1555

  2023-11-30

• A systematic review and Bayesian network meta-analysis for comparative safety assessment of favipiravir interventions in hospitalized COVID-19 patients

  Kai Yang, Jun Zeng, Wenjing Dai, Meifeng Chen, Fan Yang

  1406-1412

  2022-09-30

• Hydroxychloroquine shortened hospital stay and reduced intensive care unit admissions in hospitalized COVID-19 patients

  Ahmet Omma, Abdulsamet Erden, Hakan Apaydin, Meryem Aslan, Hüseyin Çamlı, Enes Seyda Şahiner, Serdar Can Güven, Berkan Armağan, Selma Karaahmetoğlu, Ihsan Ates, Orhan Kucuksahin

  25-31

  2022-01-31

• Efficacy of favipiravir in COVID-19: A retrospective two center comparative study

  Elif Tukenmez Tigen, Malgorzata Mikulska, Buket Erturk Sengel, Alessio Signori, Silvia Dettori, Stefania Tutino, Abdullah Emre Guner, Zekaver Odabasi, Volkan Korten, Matteo Bassetti

  1313-1319

  2024-09-30

• Intravenous high dose vitamin C and selected antiviral drugs in hospitalized COVID-19 patients: a descriptive cohort study

  Mohamad Fleifel, Jonathan Mina, Tony Haykal, Rana Asmar, Ghida El Hout, Ranime Harb, Hani Dimassi, Jacques Mokhbat, Anna Farra, Rola Husni-Samaha

  1542-1554

  2022-10-31